Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Carlson

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Medicinal Chemistry|January 1, 1990
N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Arthritis and Rheumatism|October 19, 1999
A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic ratP B Jacobson, S J Morgan, D M Wilcox, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
Pulmonary pharmacology of WAY-126299A: a dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonistR E Howell, L P Jenkins, D A Hartman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Rapamycin, a potential disease-modifying antiarthritic drugR P Carlson, D A Hartman, L A Tomchek, et al.
European Journal of Pharmacology|May 19, 1993
WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activityD Grimes, R J Sturm, L R Marinari, et al.
Agents and Actions|January 1, 1993
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2)K B Glaser, R P Carlson, A Sung, et al.
Journal of Medicinal Chemistry|January 5, 1996
Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenaseM S Malamas, R P Carlson, D Grimes, et al.
Journal of Medicinal Chemistry|April 28, 1995
Synthesis and antiinflammatory activity of certain 5,6,7,8-tetrahydroquinolines and related compoundsW Calhoun, R P Carlson, R Crossley, et al.
Journal of Medicinal Chemistry|July 1, 1986
Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonistsA F Kreft, D H Klaubert, S C Bell, et al.
Agents and Actions|June 1, 1986
The development of Wy-41,195, an orally effective antiallergic drug in animal modelsA J Lewis, R P Carlson, T J Forster, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Medicinal Chemistry|January 1, 1990
N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Arthritis and Rheumatism|October 19, 1999
A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic ratP B Jacobson, S J Morgan, D M Wilcox, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
Pulmonary pharmacology of WAY-126299A: a dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonistR E Howell, L P Jenkins, D A Hartman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Rapamycin, a potential disease-modifying antiarthritic drugR P Carlson, D A Hartman, L A Tomchek, et al.
European Journal of Pharmacology|May 19, 1993
WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activityD Grimes, R J Sturm, L R Marinari, et al.
Agents and Actions|January 1, 1993
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2)K B Glaser, R P Carlson, A Sung, et al.
Journal of Medicinal Chemistry|January 5, 1996
Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenaseM S Malamas, R P Carlson, D Grimes, et al.
Journal of Medicinal Chemistry|April 28, 1995
Synthesis and antiinflammatory activity of certain 5,6,7,8-tetrahydroquinolines and related compoundsW Calhoun, R P Carlson, R Crossley, et al.
Journal of Medicinal Chemistry|July 1, 1986
Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonistsA F Kreft, D H Klaubert, S C Bell, et al.
Agents and Actions|June 1, 1986
The development of Wy-41,195, an orally effective antiallergic drug in animal modelsA J Lewis, R P Carlson, T J Forster, et al.
Pageof 7